These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10656045)

  • 1. Inhibition of the development of the hepatic stages of Plasmodium yoelii nigeriensis by antihistaminic agents.
    Singh N; Puri SK
    Ann Trop Med Parasitol; 1999 Jun; 93(4):419-22. PubMed ID: 10656045
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemotherapy of rodent malaria. LIX. Drug combinations to impede the selection of drug resistance, Part 3: Observations on cyproheptadine, an antihistaminic agent, with chloroquine.
    Peters W; Robinson BL; Stewart LB; Butcher GA
    Ann Trop Med Parasitol; 2000 Oct; 94(7):689-97. PubMed ID: 11144810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal prophylactic activity of antihistaminic agents against Plasmodium yoelii nigeriensis infection in Swiss mice.
    Singh N; Puri SK
    Acta Trop; 1998 Jun; 69(3):255-60. PubMed ID: 9638277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
    Shukla B; Dutta GP
    J Commun Dis; 1988 Sep; 20(3):175-84. PubMed ID: 3256563
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis.
    Singh N; Puri SK
    Acta Trop; 2000 Nov; 77(2):185-93. PubMed ID: 11080509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haem polymerase as a novel target of antimalarial action of cyproheptadine.
    Agrawal R; Tripathi R; Tekwani BL; Jain SK; Dutta GP; Shukla OP
    Biochem Pharmacol; 2002 Nov; 64(9):1399-406. PubMed ID: 12392821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
    Awasthi A; Dutta GP; Bhakuni V; Tripathi R
    Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
    Beauté-Lafitte A; Altemayer-Caillard V; Chabaud AG; Landau I
    Parasite; 1994 Sep; 1(3):227-33. PubMed ID: 9140489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
    Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
    Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
    Tripathi R; Pandey SK; Rizvi A
    Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents.
    Peters W; Ekong R; Robinson BL; Warhurst DC; Pan XQ
    Ann Trop Med Parasitol; 1990 Dec; 84(6):541-51. PubMed ID: 1981663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ketotifen on the ultrastructure of the erythrocytic stages of Plasmodium yoelii.
    Cao HM; Pan XQ
    Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):545-51. PubMed ID: 2098914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro.
    Eriksson B; Courtier B; Bjŏrkman A; Miltgen F; Mazier D
    Trans R Soc Trop Med Hyg; 1991; 85(6):725-6. PubMed ID: 1801335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on hepatic oxidative stress and antioxidant defence systems during arteether treatment of Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Pandey VC
    Mol Cell Biochem; 1999 Jun; 196(1-2):169-73. PubMed ID: 10448917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Alhomida AS
    In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
    Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
    Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel (Taxotere): effectiveness against Plasmodium falciparum in vitro and Plasmodium yoelii nigeriensis in vivo.
    Seitz HM; Gottwald F; Proft J; Wingen F; Maier W
    Tokai J Exp Clin Med; 1998 Dec; 23(6):427-30. PubMed ID: 10622642
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of chloroquine resistance in Plasmodium yoelii nigeriensis.
    Kimbi HK; Fagbenro-Beyioku AF
    East Afr Med J; 1996 Oct; 73(10):634-5. PubMed ID: 8997840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
    In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.